Amwell Announces Earnings Date and Conference Participation
Amwell to Release Third Quarter Operating Results
BOSTON, Oct. 27, 2025 - Amwell (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, is set to announce its operating results for the third quarter of 2025. The announcement will occur after trading hours on an upcoming Tuesday in early November.
Conference Call Details
Following the earnings release, the Amwell management team will host a live conference call at 5 p.m. ET. This session will review the company’s operating results and provide a general update on business strategies and initiatives aimed at improving healthcare delivery.
Access to Earnings Report
The full earnings report and a live audio webcast will be available on the company’s website under the Investors section. Furthermore, a replay of the call will be accessible for approximately 90 days, ensuring all stakeholders can stay informed.
Upcoming Investor Conferences
In addition to the earnings report, Amwell's executives will be actively participating in various investor conferences:
Key Conference Participation
- Mark Hirschhorn, CFO and COO, will engage in one-on-one meetings at a prominent healthcare conference in Palm Beach Gardens on November 11.
- He is also slated to join a panel discussion on transforming healthcare systems, happening virtually at 8:00 a.m. ET on November 24 during the BTIG Digital Health Forum.
A comprehensive audio webcast of the panel discussion will also be available online for interested parties.
About Amwell
Amwell offers a unique technology-enabled care platform tailored for payers and health systems. This platform not only enhances patient access but also ensures affordable and effective healthcare. By integrating a variety of services, Amwell provides a seamless experience for patients, connecting them with numerous clinical programs available throughout the healthcare system. With nearly two decades of experience in serving major healthcare organizations globally, Amwell is committed to improving patient care through technology.
Contact Information
If you have questions regarding Amwell, you can contact:
Investors:
Asher Dewhurst
amwell@icrhealthcare.com
Media Contact:
press@amwell.com
Frequently Asked Questions
When will Amwell's third quarter results be announced?
Amwell will announce its third quarter results after market hours on an early November Tuesday.
How can I listen to the earnings call?
The earnings call will be available via a live webcast on Amwell's website.
What topics will be discussed during the investor conferences?
Panel discussions will focus on transforming healthcare systems and improving patient access to care.
Where can I find more information about Amwell's services?
Further details about Amwell and its services are available on the company's official website.
Who can I contact for investor inquiries?
Investors can reach out to Asher Dewhurst via email for any inquiries.
About The Author
Contact Kelly Martin privately here. Or send an email with ATTN: Kelly Martin as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.